Latest Medtech News
Some of the biggest challenges in MedTech come down to practical things: making procedures easier to perform, helping doctors spot problems earlier and giving clinical teams more time to focus on patients. The deals covered in this edition bring together companies working on exactly these areas, with funding and strategic backing to help bring their technologies into clinical practice and reach more patients.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
Zylox-Tonbridge and GL Capital invest HK$1.48B in LifeTech Scientific
Zylox-Tonbridge and GL Capital will jointly invest approximately HK$1.482B ($189M) in LifeTech Scientific, with the transaction expected to make their investment vehicle LifeTech’s largest single shareholder. The strategic partnership aims to combine Zylox-Tonbridge’s peripheral vascular and neurovascular businesses with LifeTech’s aortic and structural heart portfolios, creating an integrated intervention platform and expanding their international reach.
Founder Yuehui Xie: "This strategic investment reflects strong confidence in LifeTech's innovation capabilities, market position and long-term growth potential."
Mosaic emerges from stealth with $47M to develop intelligent surgical robotics
Mosaic Intelligence Labs emerged from stealth with $47M in seed funding backed by 8VC, Fundomo, Lingotto Innovation and Obvious Ventures. Founded by Dr. Ileana Pirozzi and Dr. Alison Mackanic, the company is developing sensing-enabled robotic systems that combine real-time 3D vascular mapping, instrument tracking and robotic control to help physicians navigate blood vessels with greater precision and reduce reliance on X-ray imaging.
Co-Founder and CEO Dr. Ileana Pirozzi: "We spent years in operating rooms watching extraordinary people do extraordinary things. But what really stayed with us was just how much depended on knowledge that lived in the hands and minds of the person holding the instrument,"
Luminoah raises $25M Series B to expand its FDA-cleared feeding system
Luminoah secured $25M in Series B financing, led by Sandbox Clinical Ventures, with participation from GV, Blue Venture Fund, Sands Capital and other investors. The funding will support the U.S. rollout and manufacturing scale-up of Luminoah Flow, its FDA-cleared portable enteral feeding system, as well as further development of its connected platform for tracking nutrition delivery and sharing data with clinicians.
Founder and CEO Neal Piper: "Our family’s experience inspired a mission to make tube feeding simpler and give people greater freedom."
EnVision Endoscopy raises $11.5M Series A to advance its endoscopic suturing system
EnVision Endoscopy raised $11.5M in Series A funding led by Puma Venture Capital, with participation from UTEC, Olympus Corporation of the Americas and MassVentures. The investment will support wider commercial availability, physician training, clinical evidence generation and manufacturing scale-up for its SimpleStitch Suturing System, a disposable device designed to enable tissue closure during gastrointestinal procedures using standard flexible endoscopes.
Co-Founder and CEO Dr. Azadeh Khanicheh: "This milestone positions us to build on that momentum and bring our technology to more physicians and patients,"
Raywatt raises KRW 13B Series B to advance cardiovascular imaging technology
South Korean medtech company Raywatt secured KRW 13B ($9.7M) in Series B funding, bringing its total investment to over KRW 23.5B ($17.5M). The round, backed by Intervest, Hyundai Technology Investment and other investors, will fund global expansion, manufacturing scale-up and next-generation product development. Raywatt’s FASTER OCT system delivers high-resolution intravascular images at 400 frames per second and is undergoing final FDA 510(k) review.
CEO Ha Jin-yong: "This investment is the result of investors recognizing the achievements in clinical trials, regulatory approvals, and overseas expansion,"
Kardi AI raises €5.3M Series A to expand AI-powered cardiac monitoring
Czech medtech startup Kardi AI raised €5.3M ($5.8M) in a Series A round led by Callisto Health, valuing the company at €23M ($25M). The funding will support expansion into Germany, India and the UAE, as well as development of AI models to identify arrhythmia risk earlier through its wearable ECG monitoring system.
Co-Founder and CEO Vlastimil Hrabal: "We are gradually moving beyond detecting heart rhythm disorders towards technology capable of identifying an increased risk before arrhythmia manifests."
Akara raises $5.5M to scale AI-powered hospital operations technology
Trinity College Dublin spinout Akara raised $5.5M in funding led by Locke Health, bringing its total funding to $12.3M. The investment will support expansion across hospitals and further development of its platform, which uses privacy-preserving thermal sensors and on-device AI to track activity, coordinate hospital services and reduce administrative workloads.
Co-Founder and CEO Dr. Conor McGinn: "Hospitals are under enormous pressure to do more with the people and resources they already have. We want to give staff time back and help hospitals treat more patients."
Efferon raises €4.3M to expand blood purification technology into new markets
Efferon raised €4.3M ($4.7M) from existing private investors in the DACH region to expand its hemoadsorption devices across Europe, India and Latin America. The funding will support commercial growth, distributor expansion and clinical evidence generation for its Efferon LPS and Efferon NEO systems, which are designed to remove endotoxins and inflammatory mediators from the bloodstream.
Co-Founder and CEO Dima Romashin: "The new investment will support R&D, including the development of new devices and research into applications of the technology in adjacent medical fields."
J&J invests in Francis Medical to advance prostate cancer ablation
Johnson & Johnson’s venture arm, JJDC, has made an undisclosed investment in Francis Medical to support the development and commercial expansion of its Vanquish water vapor ablation system. The funding will help advance a PMA application for a full prostate cancer management indication, expand U.S. commercial operations and strengthen physician training.
President and CEO Mike Kujak: “This is a pivotal moment in Francis Medical’s evolution as we prepare to transition from a limited commercial launch to a broader U.S. market presence,”
Quasar Medical invests in CathPrint to advance catheter manufacturing technology
Quasar Medical made a minority investment in Swedish company CathPrint and entered a strategic collaboration to develop advanced catheter solutions using its flexible printed circuit technology. The partnership aims to simplify catheter assembly, increase electrode density and support scalable manufacturing, with applications across electrophysiology mapping, pulsed field ablation and other catheter segments.
CEO Jacob Ahlsson: "Quasar’s investment reflects confidence in the potential of CathPrint’s platform and marks an important step towards commercial scale."
Zoom Invests in Medaica to Expand Remote Clinical Examination Technology
Zoom Ventures made a strategic investment in medical intelligence company Medaica to advance its Telehealth 2.0 platform, building on the company’s FDA-cleared remote examination technology. The collaboration aims to connect medical devices, clinicians and AI-assisted tools during virtual consultations, enabling more comprehensive examinations and patient monitoring from home and other care settings.
Co-Founder and CEO Stephen Randall: "With Zoom's investment, we are building an ecosystem of medical devices, AI and diagnostic tools that can bring clinical examinations to every home and care facility."
Esperto Medical receives TRISH grant to advance cardiovascular monitoring for spaceflight
Esperto Medical has received a grant from the Translational Research Institute for Space Health (TRISH) to adapt its Resonance Sonomanometry (RSM) technology for spaceflight. Using sound waves to measure blood pressure directly within arteries without calibration, the technology is designed to provide continuous monitoring of cardiovascular function, blood flow and thrombosis risk in microgravity.
Co-Founder and CMO Dr. Alaina Brinley Rajagopal: “This support from TRISH allows us to optimize our ultrasound platform for astronauts while simultaneously accelerating medical innovations that benefit critical care, remote medicine, and underserved patients on Earth."
